Mironid® Limited
Announced 05 Aug 2026$45.9M · Series B · Hospitals and Health Care · United Kingdom
Mironid Limited is an innovative new drug discovery company that develops proprietary drug candidate molecules by modulating the activity of key cell signalling proteins.
“Glasgow biopharmaceutical firm Mironid has raised £34m in a Series B funding round, which includes £8.4m equity investment from Scottish National Investment Bank — Scotland’s development bank https://lnkd.in/eKMjresE”
12 more sources tracked. Read the full press release and reporter coverage.
Sign up to read →Investors: Scottish National Investment Bank, Roche Venture Fund, Epidarex Capital, Sofinnova Partners, Biogeneration Ventures, University of Strathclyde.